{"title":"Dose verification of 2 targets simultaneously for single-isocenter stereotactic radiation therapy and radiosurgery plans.","authors":"Guoqiang Cui, Jun Duan, Fang-Fang Yin","doi":"10.1016/j.meddos.2024.12.006","DOIUrl":null,"url":null,"abstract":"<p><p>Most of conventional 2-dimensional (2D) methods verify dose of multiple targets separately one-by-one for Single-isocenter Multiple-target (SIMT) brain plans, which are inefficient and sub-optimal. This study presented a practical method to verify the dose of 2 targets simultaneously for improved efficiency and accuracy. Fifteen Stereotactic Radiation Therapy (SRT) and sixteen Stereotactic Radiosurgery (SRS) plans were used for this study. Each plan has 2 targets coincide with a plane through the plan isocenter. All plans were created in the Eclipse Treatment Planning System (TPS) using a 6 MV flattening filter free photon beam. A 2D detector array, myQA SRS was used for measurements. It has a spatial resolution of 0.4 mm and an active area of 120 × 140 mm<sup>2</sup>. It can be rotated along the longitudinal axis with a cylindrical phantom with one-degree precision. All plans were delivered with the detector array centered at the plan isocenter and rotated to intersect 2 targets. Six plans with target separations less than 70 mm were crosschecked with the SRS MapCHECK, which has an active area of 77 × 77 mm<sup>2</sup>. The measured 2D dose distributions were compared with those calculated from the TPS. Gamma-index analysis was performed using 3%/1 mm criteria and a 10% dose threshold. For all 31 SIMT brain plans measured with myQA SRS, the average and standard deviation of the gamma-passing rate was (96.8 ± 2.2)%. For 15 SRT plans and 16 SRS plans, that was (96.6 ± 2.4)% and (97.0 ± 2.1)%, respectively. For 6 plans crosschecked, the average gamma-passing rates were 96.8% vs. 94.8% with myQA SRS and SRS MapCHECK, respectively. A practical method to verify the dose of 2 targets simultaneously was demonstrated. It offers an efficient way for pretreatment verification of SIMT SRT and SRS plans with improved accuracy.</p>","PeriodicalId":49837,"journal":{"name":"Medical Dosimetry","volume":" ","pages":""},"PeriodicalIF":1.1000,"publicationDate":"2025-01-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical Dosimetry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.meddos.2024.12.006","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Most of conventional 2-dimensional (2D) methods verify dose of multiple targets separately one-by-one for Single-isocenter Multiple-target (SIMT) brain plans, which are inefficient and sub-optimal. This study presented a practical method to verify the dose of 2 targets simultaneously for improved efficiency and accuracy. Fifteen Stereotactic Radiation Therapy (SRT) and sixteen Stereotactic Radiosurgery (SRS) plans were used for this study. Each plan has 2 targets coincide with a plane through the plan isocenter. All plans were created in the Eclipse Treatment Planning System (TPS) using a 6 MV flattening filter free photon beam. A 2D detector array, myQA SRS was used for measurements. It has a spatial resolution of 0.4 mm and an active area of 120 × 140 mm2. It can be rotated along the longitudinal axis with a cylindrical phantom with one-degree precision. All plans were delivered with the detector array centered at the plan isocenter and rotated to intersect 2 targets. Six plans with target separations less than 70 mm were crosschecked with the SRS MapCHECK, which has an active area of 77 × 77 mm2. The measured 2D dose distributions were compared with those calculated from the TPS. Gamma-index analysis was performed using 3%/1 mm criteria and a 10% dose threshold. For all 31 SIMT brain plans measured with myQA SRS, the average and standard deviation of the gamma-passing rate was (96.8 ± 2.2)%. For 15 SRT plans and 16 SRS plans, that was (96.6 ± 2.4)% and (97.0 ± 2.1)%, respectively. For 6 plans crosschecked, the average gamma-passing rates were 96.8% vs. 94.8% with myQA SRS and SRS MapCHECK, respectively. A practical method to verify the dose of 2 targets simultaneously was demonstrated. It offers an efficient way for pretreatment verification of SIMT SRT and SRS plans with improved accuracy.
期刊介绍:
Medical Dosimetry, the official journal of the American Association of Medical Dosimetrists, is the key source of information on new developments for the medical dosimetrist. Practical and comprehensive in coverage, the journal features original contributions and review articles by medical dosimetrists, oncologists, physicists, and radiation therapy technologists on clinical applications and techniques of external beam, interstitial, intracavitary and intraluminal irradiation in cancer management. Articles dealing primarily with physics will be reviewed by a specially appointed team of experts in the field.